GlaxoSmithKline Pharma appoints Bhushan Akshikar as MD

He replaces Sridhar Venkatesh, who will take on a new senior post within the GSK Group on December 1, 2022 GlaxoSmithKline Pharma informed that the Board of Directors of the company at its meeting held on October 17, 2022, has appointed Bhushan Akshikar as a Managing Director for four years effective December 1, 2022. He replaces Sridhar Venkatesh, who will take on a new senior post within the GSK Group on December 1, 2022. Bhushan Akshikar is a seasoned business executive with over 26 years of experience in local and regional responsibilities in the pharmaceutical sector. In September 2011, Akshikar joined GSK India to manage specialised and commercial excellence business groups. He was named Head of the Mass Markets business in 2014. In late 2016, he was promoted to Managing Director of GSK's publicly traded business in Nigeria, Africa. He not only developed a successful business turnaround, but he also built a high a high-performing, resilient team. He has developed a strong leadership pipeline, which is reflected in the leadership position and improved competitive performance of numerous GSK marquee products. Akshikar spent 15 years with Janssen, Johnson & Johnson in different capacities overseeing both speciality and primary care business units in local and regional positions in India, South Korea, and Belgium before joining GSK. Bhushan possesses a postgraduate MBA degree in Marketing from SPJIMR as well as a Bachelor of Pharmaceutical Sciences from the University of Pune.